USD 359.17
(-3.14%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 9.2 Billion USD | 7.22% |
2022 | 8.53 Billion USD | 3.08% |
2021 | 8.28 Billion USD | 21.48% |
2020 | 6.81 Billion USD | 0.38% |
2019 | 6.79 Billion USD | 6.48% |
2018 | 6.37 Billion USD | 11.7% |
2017 | 5.71 Billion USD | 10.42% |
2016 | 5.17 Billion USD | 16.33% |
2015 | 4.44 Billion USD | -13.49% |
2014 | 5.13 Billion USD | 8.4% |
2013 | 4.74 Billion USD | 16.75% |
2012 | 4.06 Billion USD | 8.73% |
2011 | 3.73 Billion USD | 18.19% |
2010 | 3.15 Billion USD | 9.78% |
2009 | 2.87 Billion USD | -5.11% |
2008 | 3.03 Billion USD | 7.25% |
2007 | 2.82 Billion USD | 16.38% |
2006 | 2.42 Billion USD | 13.39% |
2005 | 2.14 Billion USD | 12.14% |
2004 | 1.91 Billion USD | 16.41% |
2003 | 1.64 Billion USD | 22.9% |
2002 | 1.33 Billion USD | 14.56% |
2001 | 1.16 Billion USD | 4.36% |
2000 | 1.11 Billion USD | 10.04% |
1999 | 1.01 Billion USD | 111.56% |
1998 | 479.9 Million USD | 11.17% |
1997 | 431.7 Million USD | 3.23% |
1996 | 418.2 Million USD | 11.85% |
1995 | 373.9 Million USD | 32.64% |
1994 | 281.9 Million USD | 25.4% |
1993 | 224.8 Million USD | 16.42% |
1992 | 193.1 Million USD | 26.54% |
1991 | 152.6 Million USD | 28.13% |
1990 | 119.1 Million USD | 27.24% |
1989 | 93.6 Million USD | 27.87% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 2.2 Billion USD | -9.51% |
2024 Q2 | 2.16 Billion USD | -1.9% |
2024 Q3 | 2.43 Billion USD | 12.28% |
2023 Q2 | 2.21 Billion USD | -2.98% |
2023 Q1 | 2.28 Billion USD | 2.06% |
2023 Q4 | 2.44 Billion USD | 10.01% |
2023 Q3 | 2.21 Billion USD | 0.23% |
2023 FY | 9.15 Billion USD | 7.22% |
2022 Q2 | 2.05 Billion USD | -9.81% |
2022 Q1 | 2.27 Billion USD | 2.34% |
2022 FY | 8.53 Billion USD | 3.08% |
2022 Q3 | 1.97 Billion USD | -3.51% |
2022 Q4 | 2.23 Billion USD | 12.99% |
2021 Q3 | 2.05 Billion USD | 4.48% |
2021 FY | 8.28 Billion USD | 21.48% |
2021 Q2 | 1.96 Billion USD | -3.91% |
2021 Q1 | 2.04 Billion USD | 4.98% |
2021 Q4 | 2.22 Billion USD | 8.24% |
2020 FY | 6.81 Billion USD | 0.38% |
2020 Q2 | 1.56 Billion USD | -7.87% |
2020 Q3 | 1.6 Billion USD | 2.04% |
2020 Q4 | 1.94 Billion USD | 21.69% |
2020 Q1 | 1.7 Billion USD | -2.52% |
2019 FY | 6.79 Billion USD | 6.48% |
2019 Q1 | 1.74 Billion USD | -0.17% |
2019 Q3 | 1.65 Billion USD | 0.18% |
2019 Q2 | 1.65 Billion USD | -5.28% |
2019 Q4 | 1.74 Billion USD | 5.63% |
2018 Q2 | 1.51 Billion USD | -1.69% |
2018 FY | 6.37 Billion USD | 11.7% |
2018 Q1 | 1.54 Billion USD | 1.58% |
2018 Q3 | 1.57 Billion USD | 3.89% |
2018 Q4 | 1.74 Billion USD | 10.79% |
2017 Q4 | 1.51 Billion USD | 8.97% |
2017 FY | 5.71 Billion USD | 10.42% |
2017 Q2 | 1.41 Billion USD | 2.53% |
2017 Q1 | 1.38 Billion USD | 0.8% |
2017 Q3 | 1.39 Billion USD | -1.69% |
2016 Q3 | 1.33 Billion USD | 1.22% |
2016 Q4 | 1.37 Billion USD | 3.08% |
2016 Q1 | 1.15 Billion USD | -3.02% |
2016 FY | 5.17 Billion USD | 16.33% |
2016 Q2 | 1.31 Billion USD | 13.67% |
2015 Q2 | 1.06 Billion USD | -2.65% |
2015 Q1 | 1.09 Billion USD | -13.12% |
2015 Q3 | 1.09 Billion USD | 3.01% |
2015 Q4 | 1.19 Billion USD | 8.76% |
2015 FY | 4.44 Billion USD | -13.49% |
2014 Q1 | 1.4 Billion USD | 19.25% |
2014 Q2 | 1.24 Billion USD | -11.21% |
2014 Q4 | 1.25 Billion USD | 13.03% |
2014 Q3 | 1.11 Billion USD | -10.46% |
2014 FY | 5.13 Billion USD | 8.4% |
2013 Q3 | 1.3 Billion USD | 10.4% |
2013 FY | 4.74 Billion USD | 16.75% |
2013 Q4 | 1.17 Billion USD | -10.11% |
2013 Q1 | 1.07 Billion USD | -9.72% |
2013 Q2 | 1.18 Billion USD | 9.84% |
2012 Q3 | 935 Million USD | -3.61% |
2012 FY | 4.06 Billion USD | 8.73% |
2012 Q1 | 962 Million USD | -1.94% |
2012 Q2 | 970 Million USD | 0.83% |
2012 Q4 | 1.19 Billion USD | 27.59% |
2011 Q1 | 902.8 Million USD | 4.85% |
2011 Q4 | 981 Million USD | 6.86% |
2011 Q3 | 918 Million USD | -1.54% |
2011 Q2 | 932.4 Million USD | 3.28% |
2011 FY | 3.73 Billion USD | 18.19% |
2010 Q2 | 770.8 Million USD | -0.06% |
2010 FY | 3.15 Billion USD | 9.78% |
2010 Q3 | 756.3 Million USD | -1.88% |
2010 Q4 | 861 Million USD | 13.84% |
2010 Q1 | 771.3 Million USD | 6.09% |
2009 FY | 2.87 Billion USD | -5.11% |
2009 Q2 | 708.2 Million USD | 0.23% |
2009 Q1 | 706.6 Million USD | -6.66% |
2009 Q4 | 727 Million USD | -1.25% |
2009 Q3 | 736.2 Million USD | 3.95% |
2008 Q4 | 757 Million USD | 1.31% |
2008 Q1 | 750.2 Million USD | -2.66% |
2008 FY | 3.03 Billion USD | 7.25% |
2008 Q3 | 747.2 Million USD | -4.02% |
2008 Q2 | 778.5 Million USD | 3.77% |
2007 Q4 | 770.7 Million USD | 150.8% |
2007 Q3 | 307.3 Million USD | -56.38% |
2007 Q2 | 704.5 Million USD | 5.57% |
2007 Q1 | 667.3 Million USD | 1.83% |
2007 FY | 2.82 Billion USD | 16.38% |
2006 FY | 2.42 Billion USD | 13.39% |
2006 Q4 | 655.3 Million USD | 9.6% |
2006 Q3 | 597.9 Million USD | 2.47% |
2006 Q2 | 583.5 Million USD | -1.64% |
2006 Q1 | 593.2 Million USD | 6.52% |
2005 FY | 2.14 Billion USD | 12.14% |
2005 Q3 | 524 Million USD | -2.02% |
2005 Q2 | 534.8 Million USD | 1.44% |
2005 Q1 | 527.2 Million USD | 3.25% |
2005 Q4 | 556.9 Million USD | 6.28% |
2004 FY | 1.91 Billion USD | 16.41% |
2004 Q1 | 473.7 Million USD | 5.03% |
2004 Q3 | 468.5 Million USD | 2.25% |
2004 Q4 | 510.6 Million USD | 8.99% |
2004 Q2 | 458.2 Million USD | -3.27% |
2003 Q1 | 389.7 Million USD | 7.62% |
2003 Q3 | 397.5 Million USD | -1.46% |
2003 Q2 | 403.4 Million USD | 3.52% |
2003 Q4 | 451 Million USD | 13.46% |
2003 FY | 1.64 Billion USD | 22.9% |
2002 Q2 | 328.1 Million USD | 3.57% |
2002 Q3 | 328.7 Million USD | 0.18% |
2002 Q4 | 362.1 Million USD | 10.16% |
2002 FY | 1.33 Billion USD | 14.56% |
2002 Q1 | 316.8 Million USD | 3.23% |
2001 Q3 | 283 Million USD | -1.29% |
2001 FY | 1.16 Billion USD | 4.36% |
2001 Q1 | 306.9 Million USD | 4.85% |
2001 Q2 | 286.7 Million USD | -6.58% |
2001 Q4 | 306.9 Million USD | 8.45% |
2000 FY | 1.11 Billion USD | 10.04% |
2000 Q4 | 292.7 Million USD | 8.41% |
2000 Q3 | 270 Million USD | -3.54% |
2000 Q2 | 279.9 Million USD | 1.93% |
2000 Q1 | 274.6 Million USD | 2.96% |
1999 Q2 | 252.3 Million USD | -0.79% |
1999 Q3 | 242 Million USD | -4.08% |
1999 Q4 | 266.7 Million USD | 10.21% |
1999 FY | 1.01 Billion USD | 111.56% |
1999 Q1 | 254.3 Million USD | 68.52% |
1998 Q2 | 112.7 Million USD | 4.55% |
1998 Q4 | 150.9 Million USD | 39.21% |
1998 FY | 479.9 Million USD | 11.17% |
1998 Q1 | 107.8 Million USD | -1.55% |
1998 Q3 | 108.4 Million USD | -3.82% |
1997 Q3 | 104.7 Million USD | -4.99% |
1997 FY | 431.7 Million USD | 3.23% |
1997 Q1 | 107.4 Million USD | -11.39% |
1997 Q2 | 110.2 Million USD | 2.61% |
1997 Q4 | 109.5 Million USD | 4.58% |
1996 FY | 418.2 Million USD | 11.85% |
1996 Q4 | 121.2 Million USD | 21.2% |
1996 Q3 | 100 Million USD | -1.48% |
1996 Q2 | 101.5 Million USD | 6.28% |
1996 Q1 | 95.5 Million USD | -0.52% |
1995 Q3 | 88.5 Million USD | -10.06% |
1995 Q4 | 96 Million USD | 8.47% |
1995 Q1 | 90.9 Million USD | 5.33% |
1995 Q2 | 98.4 Million USD | 8.25% |
1995 FY | 373.9 Million USD | 32.64% |
1994 FY | 281.9 Million USD | 25.4% |
1994 Q2 | 62.7 Million USD | 4.33% |
1994 Q3 | 72 Million USD | 14.83% |
1994 Q4 | 86.3 Million USD | 19.86% |
1994 Q1 | 60.1 Million USD | 5.25% |
1993 Q3 | 55.5 Million USD | -2.97% |
1993 Q1 | 55.1 Million USD | 8.46% |
1993 Q2 | 57.2 Million USD | 3.81% |
1993 FY | 224.8 Million USD | 16.42% |
1993 Q4 | 57.1 Million USD | 2.88% |
1992 Q3 | 48.5 Million USD | -4.15% |
1992 Q2 | 50.6 Million USD | 11.21% |
1992 Q4 | 50.8 Million USD | 4.74% |
1992 Q1 | 45.5 Million USD | 8.33% |
1992 FY | 193.1 Million USD | 26.54% |
1991 Q4 | 42 Million USD | 12.3% |
1991 FY | 152.6 Million USD | 28.13% |
1991 Q3 | 37.4 Million USD | 2.75% |
1991 Q1 | 36.2 Million USD | 9.37% |
1991 Q2 | 36.4 Million USD | 0.55% |
1990 Q4 | 33.1 Million USD | 14.14% |
1990 Q3 | 29 Million USD | 0.35% |
1990 Q2 | 28.9 Million USD | 2.85% |
1990 FY | 119.1 Million USD | 27.24% |
1990 Q1 | 28.1 Million USD | 11.51% |
1989 FY | 93.6 Million USD | 27.87% |
1989 Q3 | 22.8 Million USD | -2.15% |
1989 Q2 | 23.3 Million USD | 0.0% |
1989 Q1 | - USD | 100.0% |
1989 Q4 | 25.2 Million USD | 10.53% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Abbott Laboratories | 15.71 Billion USD | 41.389% |
Allurion Technologies Inc. | 120.57 Million USD | -7537.57% |
Artivion, Inc. | 223.43 Million USD | -4021.575% |
Avanos Medical, Inc. | 375.5 Million USD | -2352.463% |
Butterfly Network, Inc. | 162.46 Million USD | -5568.263% |
Butterfly Network, Inc. | 162.46 Million USD | -5568.263% |
Bio-Rad Laboratories, Inc. | 1.04 Billion USD | -779.099% |
Boston Scientific Corporation | 7.47 Billion USD | -23.148% |
Perspective Therapeutics, Inc. | 17.42 Million USD | -52746.322% |
CONMED Corporation | 564.24 Million USD | -1532.101% |
Edwards Lifesciences Corporation | 3.09 Billion USD | -197.939% |
Paragon 28, Inc. | 210.1 Million USD | -4283.151% |
Glaukos Corporation | 367.83 Million USD | -2403.561% |
Globus Medical, Inc. | 887.16 Million USD | -938.031% |
Inspire Medical Systems, Inc. | 568.49 Million USD | -1519.894% |
Integer Holdings Corporation | 250.95 Million USD | -3569.524% |
Medtronic plc | 16.12 Billion USD | 42.904% |
Nevro Corp. | 389.36 Million USD | -2265.115% |
Owlet, Inc. | 51.21 Million USD | -17879.656% |
Penumbra, Inc. | 590.87 Million USD | -1458.531% |
Vicarious Surgical Inc. | 80.66 Million USD | -11316.21% |
Smith & Nephew plc | 3.46 Billion USD | -165.619% |
Sonendo, Inc. | 68.46 Million USD | -13350.668% |
STERIS plc | 1.4 Billion USD | -557.616% |
Vapotherm, Inc. | 66.02 Million USD | -13847.747% |
Zimmer Biomet Holdings, Inc. | 3.27 Billion USD | -181.105% |